Concepedia

Olusegun O. Onabajo

OO

22

Publications

1.3K

Citations

17

H-Index

2008

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Division of Cancer Epidemiology and Genetics

Uniformed Services University of the Health Sciences

German Cancer Research Center

Olusegun O. Onabajo is an author at National Cancer Institute specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

2008–2023

22

Publications

22

Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor

Olusegun O. Onabajo, Abdul Rouf Banday, Megan L. Stanifer et al. · Nature Genetics · 2020 · 261 citations · Full text

COVID-19 and emerging viral infections: The case for interferon lambda

Ludmila Prokunina‐Olsson, Noémie Alphonse, Ruth E. Dickenson et al. · The Journal of Experimental Medicine · 2020 · 206 citations · Full text

, , +17

Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors

Candace D. Middlebrooks, Abdul Rouf Banday, Konichi Matsuda et al. · Nature Genetics · 2016 · 189 citations · Full text

, , +11

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Abdul Rouf Banday, Megan L. Stanifer, Oscar Flórez-Vargas et al. · Nature Genetics · 2022 · 132 citations · Full text

Significant mobilization of both conventional and regulatory T cells with AMD3100

Leslie S. Kean, Sharon Sen, Olusegun O. Onabajo et al. · Blood · 2011 · 76 citations · Full text

Rows per page

1–5 of 22